Oncogenic KRAS signaling in murine pancreatic acinar cells also promotes elevated histone acetylation in an AKT- and ACLY-dependent manner, even prior to tumor formation, and genetic deletion of Acly suppresses pancreatic carcinogenesis (Carrer et al. 2019). The gene discussed is ACLY; the disease is neoplasm.